MBX Biosciences, Inc.

MBX · Nasdaq · SIC 2834: Pharmaceutical Preparations
33
SEC Filings

Business Summary

PART I Item 1. B usiness. Overview We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our company was founded by global leaders with a transformative approach to peptide drug design and development. Leveraging this expertise, we designed our proprietary Precision Endocrine Peptide ("PEP ") platform to overcome the key limitations of unmodified an...

Next Earnings

Q2 FY2026 — expected 2026-09-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMBXdiscussed_in_filing Cybersecurity
topic_mentionMBXdiscussed_in_filing Cybersecurity
topic_mentionMBXdiscussed_in_filing Platform & Ecosystem
topic_mentionMBXdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-103121EDGAR107K words
2025-03-172024-12-310000950170-25-039838EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268148EDGAR24K words
2025-08-072025-06-300000950170-25-104619EDGAR
2025-05-122025-03-310000950170-25-068602EDGAR
2024-11-072024-09-300000950170-24-122840EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-120001193125-26-103118EDGAR3K words
2026-03-090001193125-26-097611EDGAR
2026-02-270001193125-26-079286EDGAR
2026-02-050001193125-26-039475EDGAR
2026-01-220001193125-26-018700EDGAR
2026-01-120001193125-26-009642EDGAR
2025-11-060001193125-25-268146EDGAR
2025-09-260001193125-25-220432EDGAR
2025-09-220001193125-25-210049EDGAR
2025-09-040001776111-25-000007EDGAR

33 total filings indexed. 17 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001776111
TickerMBX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 00e6216c508670fda475cf571ecef21fb4b4a311699eb2e9c75b88bf8b5dfe1c
parent: efc7d59f9147d61147edf036b6a5b0b1bf0e7563ee4a6bb597258e4907e22001
content hash: a86db7843308617727a52b2ffd4326d6c69d648a7a3018dcc768de94ab844c86
signed: 2026-04-13T04:46:11.382Z
sources: 6 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf